At the current price of $10, what are market expectations regarding Helix Energy Solutions Group’s future operating performance? Over the next 6 years, Helix Energy Solutions Group shares will need to reach $17 to achieve […]
What is the market’s view of Oil States’ future operating performance as reflected in the current price of $5? Oil States’ common shares will need to reach $9 to achieve average annual stock market performance […]
For its fourth fiscal quarter (ending December 31), Helix Energy Solutions Group Inc (NYSE: HLX) has reported a -1050% decline in E.P.S. from $0.02 a year ago to $-0.19 in the current quarter. This performance […]
For its fourth fiscal quarter (ending December 31), Helios Technologies Inc (NYSE: HLIO) has reported a -81% decline in E.P.S. from $0.54 a year ago to $0.10 in the current quarter. This performance was $-0.17 […]
BUSINESS ModivCare Inc., a technology-enabled healthcare services company, provides a suite of integrated supportive care solutions for public and private payors and patients. The company operates through four segments: Non-Emergency Medical Transportation (NEMT), Personal Care, […]
Banner Corp (NASDAQ: BANR) has recently experienced extremely meaningful negative changes in investment behavior: the stock’s recent price decline challenged its longer term uptrend, its longer term price trend turned down, and negative upside/downside volume […]
Erie Indemnity Co (NASDAQ: ERIE) has reported earnings for its fourth fiscal quarter (ending December 31) of $2.12 versus $1.25 for the same period a year ago — an increase of 70%. However, this result […]
Freshpet Inc (NASDAQ: FRPT) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.32 versus a loss $-0.06 for the same period a year ago. This result exceeded the consensus estimate of […]
Recent important negative changes in fundamentals have impacted Workiva Inc (NYSE: WK): the stock’s power rating fell below 50, the consensus estimate for December, 2024 decreased significantly, and the consensus estimate for December, 2025 decreased […]
For its fourth fiscal quarter (ending December 31), Theravance Biopharma Inc (NASDAQ: TBPH) has reported E.P.S. of $-0.17 compared to $-0.21 a year ago. This result fell short of the consensus estimate of $-0.00 by […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research